Boxer Capital, LLC Cyma Bay Therapeutics, Inc. Transaction History

Boxer Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.47 - $4.42 $13.9 Million - $17.7 Million	-4,000,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.32 - $7.24 $6.64 Million - $14.5 Million	2,000,000 Added 100.0%	4,000,000 $29 Million
Q4 2019 Feb 14, 2020	BUY	$1.33 - $5.93 $997,500 - $4.45 Million	750,000 Added 60.0%	2,000,000 $3.92 Million
Q1 2019 May 15, 2019	SELL	$8.16 - $13.42 $6.89 Million - $11.3 Million	-844,000 Reduced 40.31%	1,250,000 $16.6 Million
Q2 2018 Aug 14, 2018	SELL	$10.66 - $14.38 $6.6 Million - $8.9 Million	-618,986 Reduced 22.82%	2,094,000 $28.1 Million
Q1 2018 May 15, 2018	BUY	$9.0 - $15.16 $15.3 Million - $25.8 Million	1,700,000 Added 167.82%	2,712,986 $35.2 Million
Q3 2017 Nov 14, 2017	BUY	$5.95 - $8.26 $6.03 Million - $8.37 Million	1,012,986	1,012,986 $8.17 Million

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.